About Photosonix Medical

PhotoSonix Medical is developing a treatment for dermal diseases generated by bacterial biofilm, such as acne. Biofilms, which make treatment extremely difficult, shield bacteria from attack by both drugs and the immune system, often inducing a chronic inflammatory response. Photosonix’s product, CLENS™, will cut through biofilm by combining both ultrasound and violet light to kill underlying biofilm bacteria.


Key People

Mark Evan Schafer, Ph.D.
President & COO

Tessie McNeely, Ph.D.

Adam Dakin
Executive Chairman